Alanyl-glutamine Supplementation of Standard Treatment for C. Difficile Infection
NCT02053350
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
7
Enrollment
OTHER
Sponsor class
Stopped
Funding ended
Conditions
Clostridium Difficile Infection
Interventions
DRUG:
Alanyl-glutamine
Sponsor
University of Virginia